Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check4 days agoChange DetectedThe trial record now reports the study as completed rather than active but no longer recruiting. Its study status and recruitment status were updated in the latest record history.SummaryDifference0.3%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check18 days agoChange DetectedAn NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.3%

- Check25 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check32 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check39 days agoChange DetectedThe study record now indicates that results are posted, including an Adverse Events section, and reflects updated study status and contacts/locations. A new version dated 2026-09-03 was added to the record history.SummaryDifference0.3%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.